Sajith Wickramasekara, Angel Investor

Sajith Wickramasekara is the founder and CEO of Benchling, a cloud-based software platform launched in 2012 to modernize biotech R&D. Benchling is trusted by leading biotech companies to accelerate product development, streamline collaboration, and bring breakthrough innovations to market faster. He began his career as a research assistant at Duke University Medical Center and Liquidia Technologies. His career reflects a focus on biotechnology, software innovation, and scientific collaboration. From hands-on research in academic and industry labs to building Benchling into a critical infrastructure platform for life sciences, Wickramasekara has consistently worked at the intersection of biology and technology. As an angel investor, Sajith has backed ventures in health and biotech. His recent investment in Alleviate Health highlights his interest in companies developing solutions that improve patient outcomes and expand access to modern healthcare.